Cabaletta Bio, Inc. (CABA) Tops Q4 EPS by 6c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q4 EPS of ($0.40), $0.06 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• OpenAI launches open-source security program with Trail of Bits
• Morgan Stanley on Exelixis (EXEL): today's update 'mixed-to-negative at the margin'